Reunion Neuroscience Doses Last Patient in PPD Phase 2 Trial
19 May 2025 //
GLOBENEWSWIRE
Reunion Neuroscience presents REKINDLE Phase 2 Trial at ADAA 2025
07 Apr 2025 //
GLOBENEWSWIRE
Reunion To Join Premiere Maternal Mental Health Event
04 Mar 2025 //
GLOBENEWSWIRE
Reunion Neuroscience Updates Program And 2025 Milestones
06 Jan 2025 //
GLOBENEWSWIRE
Reunion Neuroscience Presents RE104 Phase 1 Data at ACNP
11 Dec 2024 //
GLOBENEWSWIRE
Reunion Partners With Seleni On Maternal Mental Health
09 Oct 2024 //
GLOBENEWSWIRE
Reunion Neuroscience Appoints Dr. Pollack As CMO
10 Sep 2024 //
GLOBENEWSWIRE
Reunion Neuroscience Joins Is Mom OK? Initiative
04 Sep 2024 //
GLOBENEWSWIRE
Reunion Doses First Patient In Phase 2 Trial Of RE104 For Depression
23 Jul 2024 //
GLOBENEWSWIRE
Reunion Publishes RE104 Preclinical Depression Disorder Potential
20 May 2024 //
GLOBENEWSWIRE
Reunion Neuroscience $103M Series A Led By MPM, Novo
02 May 2024 //
GLOBENEWSWIRE